Close Menu

E. coli and Listeria monocytogenes aren't the first things you think about when you think about curing disease. But to some researchers at this year's ASM conference, these bugs are exactly what the doctor ordered. The Therapeutic Use of Genetically Engineered Bacteria symposium highlighted new ideas from biotech and academia that call for the use of pathogenic bacteria to fight many diseases, including cancer. Dirk Brockstedt from Aduro BioTech in California presented his company's attempt at turning Listeria into an effective cancer vaccine.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Los Angeles Times reports that experts say Moderna's investigational COVID-19 vaccine results seem to be a step in the right direction, but that more testing is needed.

The Washington Post reports a new coronavirus data reporting protocol goes around the Centers for Disease Control and Prevention.

The Trump Administration has reversed its policy that could have stripped international students of their visas, the New York Times says.

In Cell this week: proteomic and metabolomic analysis of blood from COVID-19 patients, change in phosphorylation with infection, and more.